ArticleLiver cancer2026
Trajectory Modelling of Prognostic Biomarkers Linked to Liver Cancer Risk: A Systematic Review.
Article in Liver cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Liver cancer ranks as the third leading cause of cancer-related mortality. We review studies that used longitudinal clustering methods to identify trajectories of risk factors associated with risk of developing liver cancer. Methods: A systematic search of articles was conducted across three databases (MEDLINE, PubMed, and Scopus). Articles using any longitudinal clustering methods to identify trajectories of risk factors linked to liver cancer risk were considered. The review is registered on PROSPERO (CRD 42023406334). Results: Twenty-four studies were included. The people at higher risk of developing liver cancer in the general population are individuals with increasing body mass index, increasing metabolic syndrome, higher C-reactive protein, low or rare physical activity, high fasting blood glucose, and high smoking rate. Individuals with elevated risk of liver cancer in populations with liver disease had higher alcohol consumption, De Ritis ratio, AFP, FIB-4, liver fibrosis score, and stable HBsAg. Patients who already had liver cancer with increasing AFP and decreasing HBV DNA had lower survival probabilities. Three longitudinal clustering methods were identified: latent class growth modelling, Gaussian mixture models, and joint latent class modelling. Conclusion: This is the first systematic review of longitudinal clustering methods for prognostic risk factors linked to liver cancer risk. The study highlights the utility of longitudinal data in predicting liver cancer outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.